From October 6-8, clinicians, therapists and scientists gathered in Warsaw, Poland for the 2016 A-T Clinical Research Conference to discuss ways to improve the care for individuals with A-T.

Highlights from the meeting included:

  • An update on the CATNAP Study, a large pediatric neuroimaging study being performed in the UK and co-funded by the A-T Children’s Project. Distinct MRI changes as well as changes in certain brain metabolites were found in children with A-T. Although validation studies are necessary, these changes may be suitable for monitoring disease progression and measuring the effectiveness of therapies in clinical trials.
  • A discussion of certain immune parameters that might indicate a worsening disease course, allowing clinicians to identity Individuals with A-T who might need more aggressive supportive care.
  • Presentations describing changes that occur in the liver and the types of cancers that occur as people with A-T get older. Clinicians can now begin watching for changes in liver function and recommending surveillance for certain types of malignancies.
  • Presentations from clinicians developing new technologies to image the lung that may one day replace chest CT scans for individuals with A-T.
  • An update from the Italian company, EryDel, on the planning of their upcoming clinical trial for red blood cell loaded dexamethasone (the EryDex System) in A-T. Final approval from the FDA is needed before this trial can begin.
  • An update on cancer in A-T, emphasizing that physicians treating A-T patients with early or limited-stage cancers should take more aggressive approaches intended to cure the disease rather than simply managing it. Additionally, chemotherapy toxicity and supportive care were reviewed; gaps in our understanding and knowledge of cancers in the context of A-T were discussed; and the pros and cons (“who” and “when”) of bone marrow transplantation for individuals with A-T and cancer were debated. Currently, it is felt that bone marrow transplants for people with A-T should be considered on a case-by-case basis and should involve discussions with a team of medical experts.

As one of the conference sponsors, the A-T Children’s Project would like to thank the group of international clinicians and therapists who dedicate their valuable time and work tirelessly to treat and care for people with

Oops! We could not locate your form.

Related News

Jun 12 @ 4:26 am

Art of Nursing Award

A-T Clinic Nurse, Jenny Wright, RN is the recipient of the 2024 Art of Nursing award!

Jun 12 @ 4:26 am

Shining a Light on A-T at the IlluminATion Ball

The A-TCP is hosting IlluminATion: A BioPharma Leadership Ball on May 11 in Boston to shine a light

Jun 12 @ 4:26 am

NEAT Study – Phase 3 Clinical Trial of EryDex, a Low-Dose Steroid

Quince Therapeutics is advancing a phase 3 clinical trial to evaluate EryDex, a potential new treatment for ataxia-telangiectasia

Jun 12 @ 4:26 am

Measles Prevention in A-T: Recommendations from Dr. Lederman

Dr. Lederman of the A-T Clinical Center provides recommendations to keep people with A-T from catching measles.